Brief: Atea Pharmaceuticals Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Business Update
28/02/2023 22:23
Feb 28 (Reuters) - Atea Pharmaceuticals Inc AVIR.O :
* ATEA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* ATEA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.41
Source text for Eikon: ID:nGNX5Z5TDs
Further company coverage: AVIR.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Atea Pharmaceuticals
See all newsAtea Pharmaceuticals Q2 loss narrows as HCV trial expenses decline
Atea Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
Atea Pharmaceuticals, Inc. expected to post a loss of 56 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:30 AM